MICHELI, VALERIA

MICHELI, VALERIA  

Dipartimento di Scienze Cliniche e di Comunità  

Risultati 1 - 20 di 22 (tempo di esecuzione: 0.004 secondi).
Titolo Data di pubblicazione Autore(i) Tipo File Abstract
Anti-HBV treatment induces novel reverse transcriptase mutations with reflective effect on HBV S antigen 1-gen-2013 V. CentoV. MicheliC. F. Perno + Article (author) -
Brief Report : Impact of the COVID-19 Pandemic on Virological Suppression in People Living With HIV Attending a Large Italian HIV Clinic 1-gen-2021 Giacomelli, AndreaBonazzetti, CeciliaConti, FedericoPezzati, LauraMicheli, ValeriaMancon, AlessandroAlbrecht, MariaPasserini, MatteoCossu, Maria VittoriaCapetti, Amedeo FerdinandoAntinori, SpinelloGalli, Massimo + Article (author) -
Contribution of transgender sex workers to the complexity of the HIV-1 epidemic in the metropolitan area of Milan 1-gen-2020 Alessia LaiAnnalisa BergnaFrancesco R SimonettiMarco FranzettiGiorgio BozziValeria MicheliGianguglielmo ZehenderMassimo GalliClaudia Balotta + Article (author) -
Evaluation of virological response and resistance profile in HIV-1 infected patients starting a first-line integrase inhibitor-based regimen in clinical settings 1-gen-2020 Micheli, ValeriaCallegaro, Anna PaolaGazzola, Lidiad'Arminio Monforte, AntonellaPerno, Carlo Federico + Article (author) -
Evolution of transmitted HIV-1 drug resistance and viral subtypes circulation in Italy from 2006 to 2016 1-gen-2018 Capetti A.Gismondo M. R.Cicconi P.Rusconi S.Micheli V. + Article (author) -
Favorable therapeutic response with an antiretroviral salvage regimen in an HIV-1-positive subject infected with a CRF11-cpx virus 1-mag-2014 P. TauA. ManconD. MiletoM.R. GismondoM. GalliV. MicheliS. Rusconi + Article (author) -
Geographical reconstruction of the SARS‐CoV‐2 outbreak in Lombardy (Italy) during the early phase 1-gen-2020 Valeria MicheliSara Giordana RimoldiFrancesca RomeriFrancesco ComandatoreAlessandro ManconAnna GigantielloMatteo PeriniDavide MiletoCristina PaganiAlessandra LombardiMaria Rita Gismondo Article (author) -
HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels 1-gen-2016 V. CentoC. F. PernoB. MenzaghiA. D'Arminio MonforteA. ManconV. MicheliS. MonicoC. F. Perno + Article (author) -
Immunological failure in an HIV élite controller: Possible role of indirect markers of inflammation and benefit of antiretroviral therapy 15-mar-2020 Peri A. M.Micheli V.Gori A.Bandera A. + Article (author) -
Impact of circulating resistance-associated mutations on HIV pre-exposure prophylaxis (PrEP) efficacy : Modeling from antiretroviral resistance cohort analysis (ARCA) national database 1-ott-2016 R. RossottiV. MicheliM.R. GismondoS. Rusconi + Article (author) -
Improvement of ALT decay kinetics by all-oral HCV treatment : role of NS5A inhibitors and differences with IFN-based regimens 18-mag-2017 Cento, ValeriaDi Carlo, DomenicoCerrone, MaddalenaMenzaghi, BarbaraBolis, MatteoMicheli, ValeriaMonforte, Antonella D'ArminioPerno, Carlo Federico + Article (author) -
Multiclass HCV resistance to direct-acting antiviral failure in real-life patients advocates for tailored second-line therapies 1-apr-2017 Cento, ValeriaMicheli, ValeriaGrieco, AntonioPerno, Carlo F.Aghemo, A.D'Arminio Monforte, A.Mancon, A.Monico, S. + Article (author) -
Off-label use of tocilizumab for the treatment of SARS-CoV-2 pneumonia in Milan, Italy 1-giu-2020 Morena V.Bestetti G.Fossali T.Bassoli C.Torre A.Cossu M. V.Minari C.Ballone E.Mileto D.Merli S.Foschi A.Vimercati S.Bradanini L.Micheli V.Galli M.Antinori S. + Article (author) -
Optimal efficacy of interferon-free HCV retreatment after protease inhibitor failure in real life 1-ott-2017 Cento, V.Perno, C. F.Micheli, V.Menzaghi, B. + Article (author) -
A perspective Italian study on HIV-1 resistance in naive patients for antiretroviral therapy 1-gen-2001 V. MicheliM.R. GismondoBURATTI, GIORGIO + Article (author) -
Reduced neutralization of SARS-CoV-2 Omicron variant by BNT162b2 vaccinees’ sera: a preliminary evaluation 1-gen-2022 Mileto, DMicheli, VFenizia, CGagliardi, GMancon, ABracchitta, FDe Silvestri, ABiasin, MGismondo, M. R. + Article (author) -
Relapse of Kaposi's Sarcoma and HHV-8 viremia in an HIV-infected patient switching from protease inhibitor to integrase inhibitor-based antiretroviral therapy 1-gen-2016 F.R. SimonettiD. RicaboniD. CattaneoV. MicheliS. Rusconi + Article (author) -
SARS-CoV-2 mRNA vaccine BNT162b2 triggers a consistent cross-variant humoral and cellular response 1-gen-2021 Mileto, DFenizia, CGagliardi, GGigantiello, ADe Silvestri, A.Mancon, ABurgo, IRimoldi, SGMicheli, VBiasin, MGismondo, MR + Article (author) -
Switch to maraviroc with darunavir/r, both QD, in patients with suppressed HIV-1 was well tolerated but virologically inferior to standard antiretroviral therapy : 48-Week results of a randomized trial 21-nov-2017 S. RusconiV. MicheliA. FantauzziA. D'Arminio Monforte + Article (author) -
Tenofovir plasma trough concentrations in people with HIV treated with doravirine versus other antiretroviral regimens 1-dic-2021 Cattaneo D.Fusi M.Micheli V.Resnati C.Cossu M. V.Baldelli S.Antinori S. + Article (author) -